Evidence map›Paper›PMID 40612056›Full record

ArticleProceedings. IEEE International Symposium on Biomedical Imaging2025

BENCHMARKING TRANSFERABILITY OF SELF-SUPERVISED PRETRAINING FOR MULTI-ORGAN SEGMENTATION ON DIFFERENT MODALITIES.

Jue Jiang, Harini Veeraraghavan

Abstract read
In one paragraph

Article in Proceedings. IEEE International Symposium on Biomedical Imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jue JiangDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, NY, New York, USA.
Harini VeeraraghavanDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, NY, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Safer lung cancer radiotherapy delivery using novel artificial intelligence methodsR01CA258821 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Harini Veeraraghavan · 2022 to 2026
$2.5M
Artificial Intelligence powered virtual digital twins to construct and validate AI automated tools for safer MR-guided adaptive RT of abdominal cancersR01EB032825 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI Neelam Tyagi, Harini Veeraraghavan · 2023 to 2026
$1.9M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA258821NIBIB NIH HHS R01 EB032825
6 · The paper itself

Abstract

Self-supervised learning (SSL) is an approach to pretrain deep networks with unlabeled datasets by using pretext tasks that use images as "ground truth". Pretext tasks have been shown to impact accuracy of task categories, e.g. segmentation vs. classification. However, versatility of SSL features to downstream tasks involving different modalities has not been studied. We benchmarked impact of SSL tasks such as contrastive predictive coding, token self-distillation, and generative masked image modeling (MIM) with 3D vision transformer performed using 10K 3D-CTs (or 1.89M images) from various disease sites. SSL pretraining was used to assess (a) multi-organ segmentation under data-limited fine tuning, (b) feature reuse and (c) organ localization with multi-head attention. Analysis showed that pretext tasks combining MIM and token self-distillation balanced local and global attention distance, produced higher segmentation accuracy in few-shot and data-limited settings for MRI and CT. Feature reuse was impacted by similarity of pretraining and fine-tuning modality.

Indexed as

benchmarkingmasked image modelingsegmentationself-distillationSelf-supervised learning

Identifiers

PMID40612056
PMCPMC12214241

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.